TORONTO - Health Canada has authorized Moderna to conduct a clinical trial on a new mRNA vaccine that targets the form of Ebola blamed for the largest outbreak ever reported
TORONTO - Health Canada has authorized Moderna to conduct a clinical trial on a new mRNA vaccine that targets the form of Ebola blamed for the largest outbreak ever reported in the Democratic Republic of Congo.
There is no vaccine or treatment for the Bundibugyo type of Ebola, which has killed more than 1,700 people in Congo.
Health Canada authorizes mRNA vaccine trial for Ebola virus causing huge outbreak in Congo | CBC News
Canada authorizes clinical trials of Moderna Ebola vaccine
Moderna authorized to launch its Ebola vaccine clinical trials in Canada
Moderna starts human trials for Ebola vaccine amid Congo outbreak
Moderna begins Phase 1 clinical trial of Ebola vaccine against strain behind DRC outbreak
Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna's Investigational Vaccine Against Bundibugyo Ebolavirus
Moderna begins first human trial of Bundibugyo Ebola vaccine
Moderna avvia i test sul vaccino Ebola Bundibugyo mentre l'epidemia in Congo continua
Moderna begynder første forsøg med ebolavaccine
New Ebola vaccine trial launches as outbreak spreads in DR Congo
Health Canada has given Moderna the green light to launch a clinical trial for a vaccine targeting the Bundibugyo form of the…
The Phase 1 trial of the mRNA vaccine will assess the candidate vaccine's safety, determine the right dosage range and identify…
Canada's ministry of health has granted Moderna authorization to begin clinical trials on a vaccine against the Bundibugyo strain…
Moderna has vaccinated the first participants in a trial for a Bundibugyo Ebola vaccine, as the Democratic Republic of Congo…
Moderna said on Tuesday it has begun a Phase 1 clinical trial of an Ebola vaccine set to target the Bundibugyo strain, which is…
Phase 1 trial will evaluate safety and immune response for a strain of Ebola virus disease with no licensed vaccines…
